KBFS
NUVB icon

Kohmann Bosshard Financial Services’s Nuvation Bio NUVB Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,500
Closed -$22.4K – 471
2025
Q4 		$22.4K Buy
+2,500
New +$15.5K ﹤0.01% 713
2025
Q1 		– Sell
-2,500
Closed -$6.65K – 621
2024
Q4 		$6.65K Buy
+2,500
New +$6.44K ﹤0.01% 525

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Kohmann Bosshard Financial Services's NUVB Position: Q1 2026 in Review

Kohmann Bosshard Financial Services sold out of Nuvation Bio (NUVB) in Q1 2026, closing a stake of 2,500 shares — an estimated $22.4K sold.

Kohmann Bosshard Financial Services first reported a position in NUVB in Q4 2024 and held it in 2 quarters. The position peaked at $22.4K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Kohmann Bosshard Financial Services reported no remaining Nuvation Bio position as of Q1 2026 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 2,500 Nuvation Bio shares in Q1 2026, an estimated $22.4K.
  • Kohmann Bosshard Financial Services first reported a position in Nuvation Bio in Q4 2024 and held it in 2 quarters.
  • Kohmann Bosshard Financial Services's Nuvation Bio position peaked at $22.4K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2026, filed 23 Apr 2026.